Methacrylic Acid

Methacrylic Acid

SCHEMBL1394504

C=C(C)C(=O)O.C=C(C)C(N)=O.C=CC(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.60
LMNA P02545 2/20 0.50
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
FGFR4 P22455 1/20 0.41
LDHA P00338 1/20 0.38
LDHB P07195 1/20 0.38
TP53 P04637 1/20 0.36
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL28124054 0.95 TDP1 (0.67) TDP1LMNAALOX15HSD17B10ALDH1A1
Acrylic Acid SCHEMBL551868 0.95 TDP1 (0.67) TDP1LMNAALOX15HSD17B10ALDH1A1
Acrylic Acid SCHEMBL27625307 0.92 TDP1 (0.63) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL28150989 0.92 LMNA (0.53) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL1890911 0.90 ALDH1A1 (0.55) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL28878259 0.90 TDP1 (0.60) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL8024489 0.90 LMNA (0.56) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL23071293 0.89 LMNA (0.62) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL5964487 0.89 LMNA (0.62) TDP1LMNAALOX15HSD17B10ALDH1A1
Methacrylic Acid SCHEMBL137716 0.89 LMNA (0.62) TDP1LMNAALOX15HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120009621-A1 NOVEL ANTIBODY AND ANTIBODY FRAGMENT INTRODUCED NEW MODIFICATION SITES KYOWA HAKKO KIRIN CO., LTD (JP) 2012-01-12 US disclosed